Literature DB >> 11477400

The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells.

H L Weiner.   

Abstract

Mesh：

Year:  2001        PMID： 11477400     DOI： 10.1038/90604

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  55 in total

Review 1.  Getting to the guts of immune regulation.

Authors:  Janine Bilsborough; Joanne L Viney
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

2.  Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties.

Authors:  Janine Bilsborough; Thaddeus C George; Anne Norment; Joanne L Viney
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy.

Authors:  Ulrike Kämmerer; Andreas O Eggert; Michaela Kapp; Alexander D McLellan; Teunis B H Geijtenbeek; Johannes Dietl; Yvette van Kooyk; Eckhart Kämpgen
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 4.  Tolerizing allergic responses in the lung.

Authors:  C M Lloyd; J R Murdoch
Journal:  Mucosal Immunol       Date:  2010-05-26       Impact factor: 7.313

5.  Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.

Authors:  Marian Szczepanik; Krzysztof Bryniarski; Monika Tutaj; Maria Ptak; Joanna Skrzeczynska; Philip W Askenase; Wlodzimierz Ptak
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 6.  T-cell stimulation and regulation: with complements from CD46.

Authors:  Claudia Kemper; James W Verbsky; Jeffrey D Price; John P Atkinson
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells.

Authors:  Joachim Lehmann; Jochen Huehn; Maurus de la Rosa; Frank Maszyna; Ute Kretschmer; Veit Krenn; Monika Brunner; Alexander Scheffold; Alf Hamann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

8.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

9.  CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Erin E West; Matthew H Willett; Martin F Britos; Matthew R Pipeling; Roy G Brower; Rubin M Tuder; John F McDyer; Landon S King
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

10.  Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.

Authors:  Dan Frenkel; Alok S Pachori; Lunan Zhang; Adi Dembinsky-Vaknin; Dorit Farfara; Sanja Petrovic-Stojkovic; Victor J Dzau; Howard L Weiner
Journal:  Int Immunol       Date:  2009-06-10       Impact factor: 4.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.